Amoxycillin/clavulanate resistance as related to β-lactamase content in Escherichia coli strains from community-acquired urinary tract infections in Greece

Clinical Microbiology and Infection

Volumn 4, Issue 6, 1998, Pages 321-324

  Tzouvelekis, Leonidas S ^a,b   Tzelepi, Eva ^a   Maniatis, Antonios ^b   Vogiatzakis, Evangelos ^c   Paniara, Olga ^d   Tselentis, Yiannis ^e   Legakis, Nicholas J ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b Medical School   (Greece)

^c Laboratory of Microbiology   (Greece)

^d EVANGELISMOS HOSPITAL   (Greece)

^e UNIVERSITY OF CRETE   (Greece)

Author keywords

Amoxycillin clavulanate; Escherichia coli; Resistance; lactamase

Indexed keywords

AMOXICILLIN; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CELL EXTRACT; CLAVULANIC ACID; NITROCEFIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONJUGATION; BACTERIUM CULTURE; CONTROLLED STUDY; ENZYME SPECIFICITY; ESCHERICHIA COLI; GREECE; HYDROLYSIS; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; STRAIN DIFFERENCE; URINARY TRACT INFECTION;

EID: 0031925943     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00066.x     Document Type: Article

References (17)

1. Sutherland R. β-Lactam/β-lactamase inhibitor combinations: development, antibacterial activity and clinical applications. Infection 1995, 23: 191-200.
2. Wu PJ, Shannon K, Phillips I. Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics. Antimicrob Agents Chemother 1994; 38: 494-8.
3. Sanders CC, Iaconis JP, Bodey GP, Samonis G. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae- role of PSE-1 β-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests. Antimicrob Agents Chemother 1988; 32: 1365-9.
4. Stapleton P, Wu PJ, King A, Shannon K, French G, Phillips I. The incidence and mechanisms of resistance to the combination of amoxycillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2478-83.
5. Henquell C, Chanal C, Sirot D, Labia R, Sirot J. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1995; 39: 427-30.
6. Nicolas-Chanoine MH. Inhibitor-resistant β-lactamases. J Antimicrob Chemother 1997; 40: 1-3.
7. Bonomo RA, Currie-McCumber C, Shlaes DM. OHIO-1 β-lactamase resistant to mechanism-based inhibitors. FEMS Microbiol Lett 1992; 92: 79-82.
8. Prinarakis EE, Miriagou V, Tzelepi E, Gazouli M, Tzouvelekis LS. Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob Agents Chemother 1997; 41: 838-40.
9. Zhou XY, Bordon F, Sirot D, Kitzis MD, Gutmann L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob Agents Chemother 1994; 38: 1085-9.
10. Chardon H, Ferzaneh S, Labia R, et al. Analysis of β-lactamase produced by cephalothin-susceptible Escherichia coli clinical isolates resistant to co-amoxiclav and ticarcillin-clavulanic acid. The CERIB Study Group. J Antimicrob Chemother 1995, 36: 267-9.
11. Reguera JA, Baquero F, Perez-Diaz JC, Martinez JL. Factors determining resistance to β-lactams combined with β-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother 1991; 27: 569-75.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. M2A2. Villanova, Pa: NCCLS, 1992.
13. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns Rev infect Dis 1988; 10: 867-78.
14. Tzouvelekis LS, Tzelepi E, Mentis AF, Tsakris A. Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics in Klebsiella pneumoniae. J Antimicrob Chemother 1993; 31: 645-54.
15. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996; 34: 358-63.
16. Legakis NJ, Maniatis A, Tzouvelekis LS. Common mechanisms of resistance among enterobacteria isolated in Greek hospitals. Microb Drug Resist 1996, 1: 131-4.
17. Marunez JL, Vicente MF, Delgado-Iribarren A, Perez-Diaz JC, Baquero F. Small plasmids are involved in amoxycillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother 1989; 33: 595.